Opening Day: Oyster Point Pharma Off To Solid Start
Oyster Point Pharma (OYST), RAPT Therapeutics (RAPT) both finish first week as publicly-traded companies higher, Fangdd Network Group (DUO) finished flat.
LATEST IPOS:
After the market close on October 30, Oyster Point Pharma's 5M share IPO priced at $16.00, at the low end of its $16.00-$18.00 target range. On Thursday, October 31, Oyster Point Pharma opened at $16.50.
After the market close on October 30, RAPT Therapeutics' 3M share IPO priced at $12.00, at the low end of its $12.00-$14.00 target range. On Thursday, October 31, RAPT Therapeutics opened at $12.25.
Before the market open on November 1, Fangdd Network Group's 6M share IPO priced at $13.00. The deal size was reduced to 6M shares of common stock from 7M shares of common stock, and it priced at the low end of its $13.00-$15.00 range. Later that morning, FangDD Network opened at $13.00.
PERFORMANCE:
- Oyster Point Pharma finished the week higher, closing at $17.90 per share, after opening on Thursday at $16.50.
- RAPT Therapeutics finished the week slightly higher, closing at $12.70 per share, after opening on Thursday at $12.25.
- Fangdd Network Group closed on Friday at $13.00 per share, exactly where it opened earlier that morning.
UPCOMING IPOS:
Among the upcoming IPOs scheduled for this coming week are Q&K International (QK), 86bio (ETNB), Centogene (CNTG), Galera Therapeutics (GRTX), 36Kr Holdings (KRKR), CNS Pharmaceuticals (CNSP), GFL Environmental (GFL), and TELA Bio (TELA).
SAUDI ARAMCO ANNOUNCES IPO ON SAUDI EXCHANGE:
According to the New York Times' DealBook, Saudi Aramco, Saudi Arabia’s state-owned oil producer, is said to be planning "to sell an unspecified percentage of its shares on the Saudi stock exchange, the Tadawul," with trading expected to begin next month. The report said no specific date and few other details were given, but noted that bankers have said investors could value the company at about $1.5T, according to sources.
Disclosure: None.